TY - JOUR
T1 - Actions of veratridine on tetrodotoxin-sensitive voltage-gated Na+ currents, NaV1.6, in murine vas deferens myocytes
AU - Zhu, Hai Lei
AU - Wassall, Richard D.
AU - Takai, Maki
AU - Morinaga, Hidetaka
AU - Nomura, Masatoshi
AU - Cunnane, Thomas C.
AU - Teramoto, Noriyoshi
N1 - Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2009
Y1 - 2009
N2 - Background and purpose: The effects of veratridine, an alkaloid found in Liliaceae plants, on tetrodotoxin (TTX)-sensitive voltage-gated Na+ channels were investigated in mouse vas deferens. Experimental approach: Effects of veratridine on TTX-sensitive Na+ currents (INa) in vas deferens myocytes dispersed from BALB/c mice, homozygous mice with a null allele of NaV1.6 (NaV1.6-/-) and wild-type mice (NaV1.6+/+) were studied using patch-clamp techniques. Tension measurements were also performed to compare the effects of veratridine on phasic contractions in intact tissues. Key results: In whole-cell configuration, veratridine had a concentration-dependent dual action on the peak amplitude of INa: INa was enhanced by veratridine (1-10 mM), while higher concentrations (≥30 μM) inhibited INa. Additionally, two membrane current components were evoked by veratridine, namely a sustained inward current during the duration of the depolarizing rectangular pulse and a tail current at the repolarization. Although veratridine caused little shift of the voltage dependence of the steady-state inactivation curve and the activation curve for INa, veratridine enhanced a non-inactivating component of INa. Veratridine caused no detectable contractions in vas deferens from NaV1.6-/-mice, although in tissues from NaV1.6+/+ mice, veratridine (≥3 μM) induced TTX-sensitive contractions. Similarly, no detectable inward currents were evoked by veratridine in NaV1.6-/-vas deferens myocytes, while veratridine elicited both the sustained and tail currents in cells taken from NaV1.6+/+ mice. Conclusions and implications: These results suggest that veratridine possesses a dual action on INa and that the veratridineinduced activation of contraction is induced by the activation of NaV1.6 channels.
AB - Background and purpose: The effects of veratridine, an alkaloid found in Liliaceae plants, on tetrodotoxin (TTX)-sensitive voltage-gated Na+ channels were investigated in mouse vas deferens. Experimental approach: Effects of veratridine on TTX-sensitive Na+ currents (INa) in vas deferens myocytes dispersed from BALB/c mice, homozygous mice with a null allele of NaV1.6 (NaV1.6-/-) and wild-type mice (NaV1.6+/+) were studied using patch-clamp techniques. Tension measurements were also performed to compare the effects of veratridine on phasic contractions in intact tissues. Key results: In whole-cell configuration, veratridine had a concentration-dependent dual action on the peak amplitude of INa: INa was enhanced by veratridine (1-10 mM), while higher concentrations (≥30 μM) inhibited INa. Additionally, two membrane current components were evoked by veratridine, namely a sustained inward current during the duration of the depolarizing rectangular pulse and a tail current at the repolarization. Although veratridine caused little shift of the voltage dependence of the steady-state inactivation curve and the activation curve for INa, veratridine enhanced a non-inactivating component of INa. Veratridine caused no detectable contractions in vas deferens from NaV1.6-/-mice, although in tissues from NaV1.6+/+ mice, veratridine (≥3 μM) induced TTX-sensitive contractions. Similarly, no detectable inward currents were evoked by veratridine in NaV1.6-/-vas deferens myocytes, while veratridine elicited both the sustained and tail currents in cells taken from NaV1.6+/+ mice. Conclusions and implications: These results suggest that veratridine possesses a dual action on INa and that the veratridineinduced activation of contraction is induced by the activation of NaV1.6 channels.
UR - http://www.scopus.com/inward/record.url?scp=70350344962&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70350344962&partnerID=8YFLogxK
U2 - 10.1111/j.1476-5381.2009.00301.x
DO - 10.1111/j.1476-5381.2009.00301.x
M3 - Article
C2 - 19552689
AN - SCOPUS:70350344962
SN - 0007-1188
VL - 157
SP - 1483
EP - 1493
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 8
ER -